nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—Propafenone—Benzphetamine—obesity	0.237	1	CrCrCtD
Salmeterol—ADRB2—obesity	0.234	1	CbGaD
Salmeterol—ADRB2—Phenylpropanolamine—obesity	0.104	0.294	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Cimetidine—obesity	0.037	0.105	CbGbCtD
Salmeterol—CYP3A7—Cimetidine—obesity	0.037	0.105	CbGbCtD
Salmeterol—CYP2C8—Bupropion—obesity	0.0364	0.103	CbGbCtD
Salmeterol—CYP3A5—Cimetidine—obesity	0.0278	0.0785	CbGbCtD
Salmeterol—CYP2C8—Cimetidine—obesity	0.0267	0.0755	CbGbCtD
Salmeterol—CYP3A4—Sibutramine—obesity	0.0229	0.0648	CbGbCtD
Salmeterol—CYP3A4—Benzphetamine—obesity	0.0173	0.0491	CbGbCtD
Salmeterol—CYP3A4—Bupropion—obesity	0.0147	0.0417	CbGbCtD
Salmeterol—CYP3A4—Orlistat—obesity	0.012	0.034	CbGbCtD
Salmeterol—CYP3A4—Cimetidine—obesity	0.0108	0.0306	CbGbCtD
Salmeterol—CYP3A4—Topiramate—obesity	0.00709	0.02	CbGbCtD
Salmeterol—Arbutamine—ADRB3—obesity	0.000869	0.239	CrCbGaD
Salmeterol—Labetalol—ADRB3—obesity	0.000616	0.169	CrCbGaD
Salmeterol—Arbutamine—ADRB1—obesity	0.000393	0.108	CrCbGaD
Salmeterol—Salbutamol—ADRB1—obesity	0.000381	0.105	CrCbGaD
Salmeterol—Arbutamine—ADRB2—obesity	0.00033	0.0908	CrCbGaD
Salmeterol—Salbutamol—ADRB2—obesity	0.000321	0.0882	CrCbGaD
Salmeterol—Labetalol—ADRB1—obesity	0.000279	0.0766	CrCbGaD
Salmeterol—Labetalol—ADRB2—obesity	0.000234	0.0644	CrCbGaD
Salmeterol—Propafenone—ADRB1—obesity	0.000213	0.0586	CrCbGaD
Salmeterol—Headache—Phentermine—obesity	0.000208	0.00165	CcSEcCtD
Salmeterol—Rhinitis—Sibutramine—obesity	0.000207	0.00165	CcSEcCtD
Salmeterol—Nausea—Phenylpropanolamine—obesity	0.000206	0.00164	CcSEcCtD
Salmeterol—Pharyngitis—Sibutramine—obesity	0.000205	0.00163	CcSEcCtD
Salmeterol—Hyperglycaemia—Bupropion—obesity	0.000203	0.00161	CcSEcCtD
Salmeterol—Hypersensitivity—Cimetidine—obesity	0.000203	0.00161	CcSEcCtD
Salmeterol—Pneumonia—Bupropion—obesity	0.000202	0.0016	CcSEcCtD
Salmeterol—Infestation NOS—Bupropion—obesity	0.000201	0.0016	CcSEcCtD
Salmeterol—Infestation—Bupropion—obesity	0.000201	0.0016	CcSEcCtD
Salmeterol—Hyperkinesia—Topiramate—obesity	0.0002	0.00159	CcSEcCtD
Salmeterol—Diarrhoea—Diethylpropion—obesity	0.000198	0.00157	CcSEcCtD
Salmeterol—Nausea—Phentermine—obesity	0.000197	0.00157	CcSEcCtD
Salmeterol—Asthenia—Cimetidine—obesity	0.000197	0.00157	CcSEcCtD
Salmeterol—Urinary tract infection—Bupropion—obesity	0.000195	0.00155	CcSEcCtD
Salmeterol—Conjunctivitis—Bupropion—obesity	0.000195	0.00155	CcSEcCtD
Salmeterol—Ear pain—Topiramate—obesity	0.000195	0.00155	CcSEcCtD
Salmeterol—Immune system disorder—Orlistat—obesity	0.000193	0.00153	CcSEcCtD
Salmeterol—Mediastinal disorder—Orlistat—obesity	0.000193	0.00153	CcSEcCtD
Salmeterol—Sleep disorder—Topiramate—obesity	0.000192	0.00152	CcSEcCtD
Salmeterol—Dizziness—Diethylpropion—obesity	0.000191	0.00152	CcSEcCtD
Salmeterol—Epistaxis—Bupropion—obesity	0.000189	0.00151	CcSEcCtD
Salmeterol—Sinusitis—Bupropion—obesity	0.000188	0.0015	CcSEcCtD
Salmeterol—Diarrhoea—Cimetidine—obesity	0.000188	0.00149	CcSEcCtD
Salmeterol—Gastroenteritis—Topiramate—obesity	0.000187	0.00149	CcSEcCtD
Salmeterol—Mental disorder—Orlistat—obesity	0.000187	0.00149	CcSEcCtD
Salmeterol—Immune system disorder—Sibutramine—obesity	0.000187	0.00148	CcSEcCtD
Salmeterol—Malnutrition—Orlistat—obesity	0.000186	0.00148	CcSEcCtD
Salmeterol—Eczema—Topiramate—obesity	0.000185	0.00147	CcSEcCtD
Salmeterol—Arrhythmia—Sibutramine—obesity	0.000185	0.00147	CcSEcCtD
Salmeterol—Vomiting—Diethylpropion—obesity	0.000184	0.00146	CcSEcCtD
Salmeterol—Nasal congestion—Topiramate—obesity	0.000182	0.00145	CcSEcCtD
Salmeterol—Rash—Diethylpropion—obesity	0.000182	0.00145	CcSEcCtD
Salmeterol—Dermatitis—Diethylpropion—obesity	0.000182	0.00145	CcSEcCtD
Salmeterol—Dizziness—Cimetidine—obesity	0.000182	0.00144	CcSEcCtD
Salmeterol—Headache—Diethylpropion—obesity	0.000181	0.00144	CcSEcCtD
Salmeterol—Rhinitis—Bupropion—obesity	0.000181	0.00144	CcSEcCtD
Salmeterol—Malnutrition—Sibutramine—obesity	0.00018	0.00143	CcSEcCtD
Salmeterol—Back pain—Orlistat—obesity	0.00018	0.00143	CcSEcCtD
Salmeterol—Pharyngitis—Bupropion—obesity	0.000179	0.00142	CcSEcCtD
Salmeterol—Muscle spasms—Orlistat—obesity	0.000179	0.00142	CcSEcCtD
Salmeterol—Connective tissue disorder—Bupropion—obesity	0.000177	0.00141	CcSEcCtD
Salmeterol—Tension—Sibutramine—obesity	0.000177	0.0014	CcSEcCtD
Salmeterol—Nervousness—Sibutramine—obesity	0.000175	0.00139	CcSEcCtD
Salmeterol—Vomiting—Cimetidine—obesity	0.000175	0.00139	CcSEcCtD
Salmeterol—Back pain—Sibutramine—obesity	0.000174	0.00138	CcSEcCtD
Salmeterol—Rash—Cimetidine—obesity	0.000173	0.00138	CcSEcCtD
Salmeterol—Dermatitis—Cimetidine—obesity	0.000173	0.00138	CcSEcCtD
Salmeterol—Muscle spasms—Sibutramine—obesity	0.000173	0.00138	CcSEcCtD
Salmeterol—Ill-defined disorder—Orlistat—obesity	0.000173	0.00137	CcSEcCtD
Salmeterol—Headache—Cimetidine—obesity	0.000172	0.00137	CcSEcCtD
Salmeterol—Nausea—Diethylpropion—obesity	0.000172	0.00136	CcSEcCtD
Salmeterol—Angioedema—Orlistat—obesity	0.00017	0.00135	CcSEcCtD
Salmeterol—Tremor—Sibutramine—obesity	0.000169	0.00134	CcSEcCtD
Salmeterol—Malaise—Orlistat—obesity	0.000168	0.00133	CcSEcCtD
Salmeterol—Cardiac disorder—Bupropion—obesity	0.000167	0.00133	CcSEcCtD
Salmeterol—Ill-defined disorder—Sibutramine—obesity	0.000167	0.00133	CcSEcCtD
Salmeterol—Pain in extremity—Topiramate—obesity	0.000166	0.00132	CcSEcCtD
Salmeterol—Agitation—Sibutramine—obesity	0.000165	0.00131	CcSEcCtD
Salmeterol—Angioedema—Sibutramine—obesity	0.000165	0.00131	CcSEcCtD
Salmeterol—Palpitations—Orlistat—obesity	0.000164	0.00131	CcSEcCtD
Salmeterol—Migraine—Topiramate—obesity	0.000163	0.0013	CcSEcCtD
Salmeterol—Nausea—Cimetidine—obesity	0.000163	0.0013	CcSEcCtD
Salmeterol—Immune system disorder—Bupropion—obesity	0.000163	0.00129	CcSEcCtD
Salmeterol—Mediastinal disorder—Bupropion—obesity	0.000163	0.00129	CcSEcCtD
Salmeterol—Malaise—Sibutramine—obesity	0.000162	0.00129	CcSEcCtD
Salmeterol—Cough—Orlistat—obesity	0.000162	0.00129	CcSEcCtD
Salmeterol—Arrhythmia—Bupropion—obesity	0.000161	0.00128	CcSEcCtD
Salmeterol—Palpitations—Sibutramine—obesity	0.000159	0.00126	CcSEcCtD
Salmeterol—Irritability—Topiramate—obesity	0.000158	0.00126	CcSEcCtD
Salmeterol—Myalgia—Orlistat—obesity	0.000158	0.00126	CcSEcCtD
Salmeterol—Chest pain—Orlistat—obesity	0.000158	0.00126	CcSEcCtD
Salmeterol—Mental disorder—Bupropion—obesity	0.000158	0.00125	CcSEcCtD
Salmeterol—Anxiety—Orlistat—obesity	0.000158	0.00125	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000157	0.00125	CcSEcCtD
Salmeterol—Cough—Sibutramine—obesity	0.000157	0.00125	CcSEcCtD
Salmeterol—Malnutrition—Bupropion—obesity	0.000157	0.00125	CcSEcCtD
Salmeterol—Discomfort—Orlistat—obesity	0.000156	0.00124	CcSEcCtD
Salmeterol—Hypertension—Sibutramine—obesity	0.000155	0.00123	CcSEcCtD
Salmeterol—Dry mouth—Orlistat—obesity	0.000155	0.00123	CcSEcCtD
Salmeterol—Tension—Bupropion—obesity	0.000154	0.00122	CcSEcCtD
Salmeterol—Chest pain—Sibutramine—obesity	0.000153	0.00122	CcSEcCtD
Salmeterol—Myalgia—Sibutramine—obesity	0.000153	0.00122	CcSEcCtD
Salmeterol—Arthralgia—Sibutramine—obesity	0.000153	0.00122	CcSEcCtD
Salmeterol—Anxiety—Sibutramine—obesity	0.000153	0.00121	CcSEcCtD
Salmeterol—Nervousness—Bupropion—obesity	0.000152	0.00121	CcSEcCtD
Salmeterol—Anaphylactic shock—Orlistat—obesity	0.000152	0.00121	CcSEcCtD
Salmeterol—Oedema—Orlistat—obesity	0.000152	0.00121	CcSEcCtD
Salmeterol—Back pain—Bupropion—obesity	0.000152	0.00121	CcSEcCtD
Salmeterol—Abdominal pain upper—Topiramate—obesity	0.000152	0.0012	CcSEcCtD
Salmeterol—Discomfort—Sibutramine—obesity	0.000151	0.0012	CcSEcCtD
Salmeterol—Muscle spasms—Bupropion—obesity	0.000151	0.0012	CcSEcCtD
Salmeterol—Infection—Orlistat—obesity	0.000151	0.0012	CcSEcCtD
Salmeterol—Dry mouth—Sibutramine—obesity	0.00015	0.00119	CcSEcCtD
Salmeterol—Nervous system disorder—Orlistat—obesity	0.000149	0.00118	CcSEcCtD
Salmeterol—Nasopharyngitis—Topiramate—obesity	0.000148	0.00118	CcSEcCtD
Salmeterol—Skin disorder—Orlistat—obesity	0.000147	0.00117	CcSEcCtD
Salmeterol—Tremor—Bupropion—obesity	0.000147	0.00117	CcSEcCtD
Salmeterol—Oedema—Sibutramine—obesity	0.000147	0.00117	CcSEcCtD
Salmeterol—Anaphylactic shock—Sibutramine—obesity	0.000147	0.00117	CcSEcCtD
Salmeterol—Infection—Sibutramine—obesity	0.000146	0.00116	CcSEcCtD
Salmeterol—Ill-defined disorder—Bupropion—obesity	0.000146	0.00116	CcSEcCtD
Salmeterol—Agitation—Bupropion—obesity	0.000144	0.00115	CcSEcCtD
Salmeterol—Asthma—Topiramate—obesity	0.000144	0.00114	CcSEcCtD
Salmeterol—Angioedema—Bupropion—obesity	0.000143	0.00114	CcSEcCtD
Salmeterol—Tachycardia—Sibutramine—obesity	0.000143	0.00114	CcSEcCtD
Salmeterol—Skin disorder—Sibutramine—obesity	0.000143	0.00113	CcSEcCtD
Salmeterol—Malaise—Bupropion—obesity	0.000142	0.00112	CcSEcCtD
Salmeterol—Palpitations—Bupropion—obesity	0.000139	0.0011	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Orlistat—obesity	0.000138	0.0011	CcSEcCtD
Salmeterol—Bronchitis—Topiramate—obesity	0.000138	0.0011	CcSEcCtD
Salmeterol—Abdominal discomfort—Topiramate—obesity	0.000138	0.00109	CcSEcCtD
Salmeterol—Insomnia—Orlistat—obesity	0.000137	0.00109	CcSEcCtD
Salmeterol—Cough—Bupropion—obesity	0.000137	0.00109	CcSEcCtD
Salmeterol—Paraesthesia—Orlistat—obesity	0.000136	0.00108	CcSEcCtD
Salmeterol—Hypertension—Bupropion—obesity	0.000136	0.00108	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Sibutramine—obesity	0.000134	0.00106	CcSEcCtD
Salmeterol—Dyspepsia—Orlistat—obesity	0.000134	0.00106	CcSEcCtD
Salmeterol—Myalgia—Bupropion—obesity	0.000134	0.00106	CcSEcCtD
Salmeterol—Arthralgia—Bupropion—obesity	0.000134	0.00106	CcSEcCtD
Salmeterol—Chest pain—Bupropion—obesity	0.000134	0.00106	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Topiramate—obesity	0.000133	0.00106	CcSEcCtD
Salmeterol—Anxiety—Bupropion—obesity	0.000133	0.00106	CcSEcCtD
Salmeterol—Insomnia—Sibutramine—obesity	0.000133	0.00106	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000133	0.00105	CcSEcCtD
Salmeterol—Discomfort—Bupropion—obesity	0.000132	0.00105	CcSEcCtD
Salmeterol—Paraesthesia—Sibutramine—obesity	0.000132	0.00105	CcSEcCtD
Salmeterol—Dyspnoea—Sibutramine—obesity	0.000131	0.00104	CcSEcCtD
Salmeterol—Fatigue—Orlistat—obesity	0.000131	0.00104	CcSEcCtD
Salmeterol—Dry mouth—Bupropion—obesity	0.000131	0.00104	CcSEcCtD
Salmeterol—Pain—Orlistat—obesity	0.00013	0.00103	CcSEcCtD
Salmeterol—Hyperglycaemia—Topiramate—obesity	0.000129	0.00103	CcSEcCtD
Salmeterol—Dyspepsia—Sibutramine—obesity	0.000129	0.00103	CcSEcCtD
Salmeterol—Pneumonia—Topiramate—obesity	0.000129	0.00102	CcSEcCtD
Salmeterol—Anaphylactic shock—Bupropion—obesity	0.000128	0.00102	CcSEcCtD
Salmeterol—Oedema—Bupropion—obesity	0.000128	0.00102	CcSEcCtD
Salmeterol—Infestation NOS—Topiramate—obesity	0.000128	0.00102	CcSEcCtD
Salmeterol—Infestation—Topiramate—obesity	0.000128	0.00102	CcSEcCtD
Salmeterol—Infection—Bupropion—obesity	0.000127	0.00101	CcSEcCtD
Salmeterol—Pain—Sibutramine—obesity	0.000126	0.000998	CcSEcCtD
Salmeterol—Constipation—Sibutramine—obesity	0.000126	0.000998	CcSEcCtD
Salmeterol—Nervous system disorder—Bupropion—obesity	0.000126	0.000998	CcSEcCtD
Salmeterol—Feeling abnormal—Orlistat—obesity	0.000125	0.000994	CcSEcCtD
Salmeterol—Tachycardia—Bupropion—obesity	0.000125	0.000993	CcSEcCtD
Salmeterol—Skin disorder—Bupropion—obesity	0.000124	0.000989	CcSEcCtD
Salmeterol—Conjunctivitis—Topiramate—obesity	0.000124	0.000988	CcSEcCtD
Salmeterol—Urinary tract infection—Topiramate—obesity	0.000124	0.000988	CcSEcCtD
Salmeterol—Gastrointestinal pain—Orlistat—obesity	0.000124	0.000986	CcSEcCtD
Salmeterol—Feeling abnormal—Sibutramine—obesity	0.000121	0.000962	CcSEcCtD
Salmeterol—Epistaxis—Topiramate—obesity	0.000121	0.000959	CcSEcCtD
Salmeterol—Urticaria—Orlistat—obesity	0.000121	0.000958	CcSEcCtD
Salmeterol—Gastrointestinal pain—Sibutramine—obesity	0.00012	0.000955	CcSEcCtD
Salmeterol—Sinusitis—Topiramate—obesity	0.00012	0.000954	CcSEcCtD
Salmeterol—Abdominal pain—Orlistat—obesity	0.00012	0.000954	CcSEcCtD
Salmeterol—Body temperature increased—Orlistat—obesity	0.00012	0.000954	CcSEcCtD
Salmeterol—Urticaria—Sibutramine—obesity	0.000117	0.000927	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Bupropion—obesity	0.000117	0.000927	CcSEcCtD
Salmeterol—Body temperature increased—Sibutramine—obesity	0.000116	0.000923	CcSEcCtD
Salmeterol—Abdominal pain—Sibutramine—obesity	0.000116	0.000923	CcSEcCtD
Salmeterol—Insomnia—Bupropion—obesity	0.000116	0.00092	CcSEcCtD
Salmeterol—Rhinitis—Topiramate—obesity	0.000115	0.000915	CcSEcCtD
Salmeterol—Paraesthesia—Bupropion—obesity	0.000115	0.000914	CcSEcCtD
Salmeterol—Dyspnoea—Bupropion—obesity	0.000114	0.000907	CcSEcCtD
Salmeterol—Pharyngitis—Topiramate—obesity	0.000114	0.000906	CcSEcCtD
Salmeterol—Connective tissue disorder—Topiramate—obesity	0.000113	0.000897	CcSEcCtD
Salmeterol—Dyspepsia—Bupropion—obesity	0.000113	0.000896	CcSEcCtD
Salmeterol—Hypersensitivity—Orlistat—obesity	0.000112	0.000889	CcSEcCtD
Salmeterol—Fatigue—Bupropion—obesity	0.00011	0.000877	CcSEcCtD
Salmeterol—Constipation—Bupropion—obesity	0.00011	0.00087	CcSEcCtD
Salmeterol—Pain—Bupropion—obesity	0.00011	0.00087	CcSEcCtD
Salmeterol—Asthenia—Orlistat—obesity	0.000109	0.000865	CcSEcCtD
Salmeterol—Hypersensitivity—Sibutramine—obesity	0.000108	0.00086	CcSEcCtD
Salmeterol—Cardiac disorder—Topiramate—obesity	0.000107	0.000847	CcSEcCtD
Salmeterol—Feeling abnormal—Bupropion—obesity	0.000106	0.000839	CcSEcCtD
Salmeterol—Asthenia—Sibutramine—obesity	0.000105	0.000838	CcSEcCtD
Salmeterol—Gastrointestinal pain—Bupropion—obesity	0.000105	0.000832	CcSEcCtD
Salmeterol—Diarrhoea—Orlistat—obesity	0.000104	0.000825	CcSEcCtD
Salmeterol—Immune system disorder—Topiramate—obesity	0.000104	0.000824	CcSEcCtD
Salmeterol—Mediastinal disorder—Topiramate—obesity	0.000104	0.000823	CcSEcCtD
Salmeterol—Urticaria—Bupropion—obesity	0.000102	0.000808	CcSEcCtD
Salmeterol—Abdominal pain—Bupropion—obesity	0.000101	0.000805	CcSEcCtD
Salmeterol—Body temperature increased—Bupropion—obesity	0.000101	0.000805	CcSEcCtD
Salmeterol—Mental disorder—Topiramate—obesity	0.000101	0.0008	CcSEcCtD
Salmeterol—Diarrhoea—Sibutramine—obesity	0.000101	0.000799	CcSEcCtD
Salmeterol—Dizziness—Orlistat—obesity	0.0001	0.000798	CcSEcCtD
Salmeterol—Malnutrition—Topiramate—obesity	0.0001	0.000794	CcSEcCtD
Salmeterol—Tension—Topiramate—obesity	9.81e-05	0.00078	CcSEcCtD
Salmeterol—Dizziness—Sibutramine—obesity	9.72e-05	0.000772	CcSEcCtD
Salmeterol—Nervousness—Topiramate—obesity	9.71e-05	0.000772	CcSEcCtD
Salmeterol—Back pain—Topiramate—obesity	9.67e-05	0.000768	CcSEcCtD
Salmeterol—Vomiting—Orlistat—obesity	9.65e-05	0.000767	CcSEcCtD
Salmeterol—Muscle spasms—Topiramate—obesity	9.61e-05	0.000764	CcSEcCtD
Salmeterol—Rash—Orlistat—obesity	9.57e-05	0.000761	CcSEcCtD
Salmeterol—Dermatitis—Orlistat—obesity	9.56e-05	0.00076	CcSEcCtD
Salmeterol—Headache—Orlistat—obesity	9.51e-05	0.000756	CcSEcCtD
Salmeterol—Hypersensitivity—Bupropion—obesity	9.44e-05	0.00075	CcSEcCtD
Salmeterol—Tremor—Topiramate—obesity	9.37e-05	0.000744	CcSEcCtD
Salmeterol—Vomiting—Sibutramine—obesity	9.34e-05	0.000742	CcSEcCtD
Salmeterol—Ill-defined disorder—Topiramate—obesity	9.28e-05	0.000737	CcSEcCtD
Salmeterol—Rash—Sibutramine—obesity	9.26e-05	0.000736	CcSEcCtD
Salmeterol—Dermatitis—Sibutramine—obesity	9.26e-05	0.000735	CcSEcCtD
Salmeterol—Headache—Sibutramine—obesity	9.21e-05	0.000731	CcSEcCtD
Salmeterol—Asthenia—Bupropion—obesity	9.19e-05	0.00073	CcSEcCtD
Salmeterol—Agitation—Topiramate—obesity	9.19e-05	0.00073	CcSEcCtD
Salmeterol—Nausea—Orlistat—obesity	9.02e-05	0.000716	CcSEcCtD
Salmeterol—Malaise—Topiramate—obesity	9.02e-05	0.000716	CcSEcCtD
Salmeterol—Palpitations—Topiramate—obesity	8.84e-05	0.000702	CcSEcCtD
Salmeterol—Diarrhoea—Bupropion—obesity	8.76e-05	0.000696	CcSEcCtD
Salmeterol—Nausea—Sibutramine—obesity	8.73e-05	0.000693	CcSEcCtD
Salmeterol—Cough—Topiramate—obesity	8.73e-05	0.000693	CcSEcCtD
Salmeterol—Hypertension—Topiramate—obesity	8.63e-05	0.000686	CcSEcCtD
Salmeterol—Myalgia—Topiramate—obesity	8.51e-05	0.000676	CcSEcCtD
Salmeterol—Arthralgia—Topiramate—obesity	8.51e-05	0.000676	CcSEcCtD
Salmeterol—Chest pain—Topiramate—obesity	8.51e-05	0.000676	CcSEcCtD
Salmeterol—Anxiety—Topiramate—obesity	8.48e-05	0.000674	CcSEcCtD
Salmeterol—Dizziness—Bupropion—obesity	8.47e-05	0.000673	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.45e-05	0.000672	CcSEcCtD
Salmeterol—Discomfort—Topiramate—obesity	8.41e-05	0.000668	CcSEcCtD
Salmeterol—Dry mouth—Topiramate—obesity	8.33e-05	0.000661	CcSEcCtD
Salmeterol—Oedema—Topiramate—obesity	8.16e-05	0.000648	CcSEcCtD
Salmeterol—Vomiting—Bupropion—obesity	8.14e-05	0.000647	CcSEcCtD
Salmeterol—Infection—Topiramate—obesity	8.11e-05	0.000644	CcSEcCtD
Salmeterol—Rash—Bupropion—obesity	8.08e-05	0.000642	CcSEcCtD
Salmeterol—Dermatitis—Bupropion—obesity	8.07e-05	0.000641	CcSEcCtD
Salmeterol—Headache—Bupropion—obesity	8.03e-05	0.000638	CcSEcCtD
Salmeterol—Nervous system disorder—Topiramate—obesity	8e-05	0.000636	CcSEcCtD
Salmeterol—Tachycardia—Topiramate—obesity	7.97e-05	0.000633	CcSEcCtD
Salmeterol—Skin disorder—Topiramate—obesity	7.93e-05	0.00063	CcSEcCtD
Salmeterol—Nausea—Bupropion—obesity	7.61e-05	0.000605	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Topiramate—obesity	7.44e-05	0.000591	CcSEcCtD
Salmeterol—Insomnia—Topiramate—obesity	7.38e-05	0.000586	CcSEcCtD
Salmeterol—Paraesthesia—Topiramate—obesity	7.33e-05	0.000582	CcSEcCtD
Salmeterol—Dyspnoea—Topiramate—obesity	7.28e-05	0.000578	CcSEcCtD
Salmeterol—Dyspepsia—Topiramate—obesity	7.18e-05	0.000571	CcSEcCtD
Salmeterol—Fatigue—Topiramate—obesity	7.04e-05	0.000559	CcSEcCtD
Salmeterol—Pain—Topiramate—obesity	6.98e-05	0.000554	CcSEcCtD
Salmeterol—Constipation—Topiramate—obesity	6.98e-05	0.000554	CcSEcCtD
Salmeterol—Feeling abnormal—Topiramate—obesity	6.73e-05	0.000534	CcSEcCtD
Salmeterol—Gastrointestinal pain—Topiramate—obesity	6.67e-05	0.00053	CcSEcCtD
Salmeterol—Urticaria—Topiramate—obesity	6.48e-05	0.000515	CcSEcCtD
Salmeterol—Body temperature increased—Topiramate—obesity	6.45e-05	0.000513	CcSEcCtD
Salmeterol—Abdominal pain—Topiramate—obesity	6.45e-05	0.000513	CcSEcCtD
Salmeterol—Hypersensitivity—Topiramate—obesity	6.01e-05	0.000478	CcSEcCtD
Salmeterol—Asthenia—Topiramate—obesity	5.86e-05	0.000465	CcSEcCtD
Salmeterol—Diarrhoea—Topiramate—obesity	5.58e-05	0.000444	CcSEcCtD
Salmeterol—Dizziness—Topiramate—obesity	5.4e-05	0.000429	CcSEcCtD
Salmeterol—Vomiting—Topiramate—obesity	5.19e-05	0.000412	CcSEcCtD
Salmeterol—Rash—Topiramate—obesity	5.15e-05	0.000409	CcSEcCtD
Salmeterol—Dermatitis—Topiramate—obesity	5.14e-05	0.000408	CcSEcCtD
Salmeterol—Headache—Topiramate—obesity	5.11e-05	0.000406	CcSEcCtD
Salmeterol—Nausea—Topiramate—obesity	4.85e-05	0.000385	CcSEcCtD
Salmeterol—CYP3A4—Metabolism—OXCT1—obesity	6.82e-06	0.00015	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SDC1—obesity	6.78e-06	0.000149	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GPX1—obesity	6.76e-06	0.000148	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SOCS1—obesity	6.76e-06	0.000148	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2E1—obesity	6.73e-06	0.000148	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PIK3CD—obesity	6.7e-06	0.000147	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AKR1C3—obesity	6.67e-06	0.000146	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SOCS3—obesity	6.67e-06	0.000146	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NQO1—obesity	6.66e-06	0.000146	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SRD5A1—obesity	6.64e-06	0.000146	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PNLIP—obesity	6.64e-06	0.000146	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CD36—obesity	6.58e-06	0.000144	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SCARB1—obesity	6.57e-06	0.000144	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GNB3—obesity	6.53e-06	0.000143	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SDC3—obesity	6.48e-06	0.000142	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—obesity	6.48e-06	0.000142	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—TYK2—obesity	6.44e-06	0.000141	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	6.43e-06	0.000141	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF2—obesity	6.42e-06	0.000141	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—obesity	6.4e-06	0.00014	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—RHOA—obesity	6.39e-06	0.00014	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GCG—obesity	6.38e-06	0.00014	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC2A4—obesity	6.38e-06	0.00014	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SREBF1—obesity	6.38e-06	0.00014	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—GNAS—obesity	6.36e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—STS—obesity	6.34e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HK2—obesity	6.34e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP26B1—obesity	6.34e-06	0.000139	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PIK3R1—obesity	6.32e-06	0.000139	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYCS—obesity	6.3e-06	0.000138	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MTHFR—obesity	6.24e-06	0.000137	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOB—obesity	6.23e-06	0.000137	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT2—obesity	6.2e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARD—obesity	6.2e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GGT1—obesity	6.18e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GOT1—obesity	6.18e-06	0.000136	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARA—obesity	6.12e-06	0.000134	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.12e-06	0.000134	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NCOA1—obesity	6.09e-06	0.000134	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL5—obesity	6.08e-06	0.000133	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC27A1—obesity	6.08e-06	0.000133	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—FASN—obesity	6.07e-06	0.000133	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—BCHE—obesity	6.05e-06	0.000133	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—STK11—obesity	6e-06	0.000132	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP19A1—obesity	6e-06	0.000132	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GLUL—obesity	5.96e-06	0.000131	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FABP4—obesity	5.96e-06	0.000131	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LPL—obesity	5.95e-06	0.00013	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AGT—obesity	5.93e-06	0.00013	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FOXO1—obesity	5.9e-06	0.000129	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RPS6KB1—obesity	5.89e-06	0.000129	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PIK3CB—obesity	5.84e-06	0.000128	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2E1—obesity	5.83e-06	0.000128	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOE—obesity	5.81e-06	0.000127	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NQO1—obesity	5.77e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CAV1—obesity	5.75e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—APOA1—obesity	5.74e-06	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ECHS1—obesity	5.65e-06	0.000124	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HSD11B1—obesity	5.65e-06	0.000124	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—UCP3—obesity	5.65e-06	0.000124	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—UCP2—obesity	5.65e-06	0.000124	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.65e-06	0.000124	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.6e-06	0.000123	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—COMT—obesity	5.58e-06	0.000122	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ADH1B—obesity	5.56e-06	0.000122	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC2A4—obesity	5.53e-06	0.000121	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCG—obesity	5.53e-06	0.000121	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GNB3—obesity	5.5e-06	0.000121	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARGC1A—obesity	5.5e-06	0.000121	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKCD—obesity	5.48e-06	0.00012	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMOX1—obesity	5.48e-06	0.00012	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARGC1B—obesity	5.47e-06	0.00012	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GPAM—obesity	5.47e-06	0.00012	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ACSL1—obesity	5.47e-06	0.00012	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYCS—obesity	5.46e-06	0.00012	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HTR2A—obesity	5.36e-06	0.000118	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GNAS—obesity	5.36e-06	0.000117	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GGT1—obesity	5.35e-06	0.000117	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GOT1—obesity	5.35e-06	0.000117	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—C3—obesity	5.35e-06	0.000117	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FADS1—obesity	5.31e-06	0.000116	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HADH—obesity	5.31e-06	0.000116	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PCK1—obesity	5.31e-06	0.000116	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NCOA1—obesity	5.27e-06	0.000116	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOB—obesity	5.25e-06	0.000115	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3CG—obesity	5.24e-06	0.000115	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—STK11—obesity	5.2e-06	0.000114	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP19A1—obesity	5.2e-06	0.000114	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ACP5—obesity	5.17e-06	0.000113	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IRS2—obesity	5.09e-06	0.000112	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AGT—obesity	5.09e-06	0.000112	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARG—obesity	5.06e-06	0.000111	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—G6PD—obesity	5.04e-06	0.00011	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPL—obesity	5.01e-06	0.00011	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—obesity	4.99e-06	0.000109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LEP—obesity	4.98e-06	0.000109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOE—obesity	4.98e-06	0.000109	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HK1—obesity	4.97e-06	0.000109	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SREBF2—obesity	4.97e-06	0.000109	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—INS—obesity	4.96e-06	0.000109	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CAV1—obesity	4.94e-06	0.000108	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—APOA1—obesity	4.93e-06	0.000108	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GPX1—obesity	4.89e-06	0.000107	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—COMT—obesity	4.83e-06	0.000106	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPA—obesity	4.8e-06	0.000105	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GNB3—obesity	4.77e-06	0.000105	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARGC1A—obesity	4.77e-06	0.000105	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—ESR1—obesity	4.76e-06	0.000104	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CD36—obesity	4.76e-06	0.000104	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMOX1—obesity	4.74e-06	0.000104	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKCB—obesity	4.7e-06	0.000103	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—F2—obesity	4.7e-06	0.000103	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPIN1—obesity	4.7e-06	0.000103	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—BAD—obesity	4.65e-06	0.000102	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GNAS—obesity	4.64e-06	0.000102	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3CD—obesity	4.61e-06	0.000101	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA5—obesity	4.61e-06	0.000101	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALB—obesity	4.55e-06	9.98e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOB—obesity	4.54e-06	9.97e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MTHFR—obesity	4.51e-06	9.89e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3CG—obesity	4.5e-06	9.87e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IRS1—obesity	4.45e-06	9.75e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARA—obesity	4.42e-06	9.7e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC22A1—obesity	4.39e-06	9.64e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CLOCK—obesity	4.39e-06	9.64e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3R1—obesity	4.35e-06	9.54e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NOS3—obesity	4.35e-06	9.54e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPL—obesity	4.34e-06	9.52e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AGT—obesity	4.29e-06	9.4e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—obesity	4.28e-06	9.39e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SULT2A1—obesity	4.28e-06	9.39e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GLP1R—obesity	4.28e-06	9.39e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—INS—obesity	4.26e-06	9.34e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GPX1—obesity	4.23e-06	9.28e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DPYD—obesity	4.21e-06	9.24e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOE—obesity	4.2e-06	9.21e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—obesity	4.19e-06	9.19e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CAV1—obesity	4.16e-06	9.12e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—APOA1—obesity	4.15e-06	9.1e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CD36—obesity	4.12e-06	9.04e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1—obesity	4.12e-06	9.03e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AKT2—obesity	4.12e-06	9.03e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRKAR2B—obesity	4.05e-06	8.89e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DCN—obesity	4.03e-06	8.83e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3CB—obesity	4.02e-06	8.81e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—obesity	3.98e-06	8.73e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3CD—obesity	3.95e-06	8.67e-05	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	3.92e-06	8.59e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CPT1A—obesity	3.92e-06	8.59e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SERPINE1—obesity	3.91e-06	8.58e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MTHFR—obesity	3.91e-06	8.57e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NAMPT—obesity	3.84e-06	8.42e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARA—obesity	3.83e-06	8.41e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LIPC—obesity	3.82e-06	8.37e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCK—obesity	3.82e-06	8.37e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TYK2—obesity	3.8e-06	8.34e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOC3—obesity	3.79e-06	8.32e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3CG—obesity	3.79e-06	8.31e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RHOA—obesity	3.77e-06	8.28e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOS3—obesity	3.73e-06	8.19e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3R1—obesity	3.73e-06	8.19e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AGT—obesity	3.71e-06	8.14e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CETP—obesity	3.68e-06	8.07e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARG—obesity	3.66e-06	8.02e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SDC1—obesity	3.64e-06	7.98e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOE—obesity	3.64e-06	7.98e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—obesity	3.61e-06	7.91e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CAV1—obesity	3.6e-06	7.9e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—APOA1—obesity	3.59e-06	7.88e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—INS—obesity	3.59e-06	7.87e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKR1C3—obesity	3.58e-06	7.85e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PIK3CA—obesity	3.56e-06	7.8e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SCARB1—obesity	3.53e-06	7.73e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3CB—obesity	3.45e-06	7.56e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MTOR—obesity	3.45e-06	7.56e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.44e-06	7.55e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SREBF1—obesity	3.42e-06	7.51e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3CD—obesity	3.33e-06	7.31e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT2—obesity	3.33e-06	7.3e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALB—obesity	3.29e-06	7.21e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3CG—obesity	3.28e-06	7.2e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FASN—obesity	3.26e-06	7.15e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—BCHE—obesity	3.24e-06	7.12e-05	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AKT1—obesity	3.2e-06	7.02e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARG—obesity	3.17e-06	6.95e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—obesity	3.15e-06	6.91e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3R1—obesity	3.15e-06	6.9e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NOS3—obesity	3.15e-06	6.9e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2E1—obesity	3.13e-06	6.87e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—obesity	3.12e-06	6.85e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—INS—obesity	3.11e-06	6.81e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NQO1—obesity	3.1e-06	6.79e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MMP9—obesity	3e-06	6.57e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCG—obesity	2.97e-06	6.51e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC2A4—obesity	2.97e-06	6.51e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYCS—obesity	2.93e-06	6.42e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MAPK8—obesity	2.91e-06	6.39e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AKT1—obesity	2.91e-06	6.37e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3CB—obesity	2.9e-06	6.37e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3CD—obesity	2.89e-06	6.33e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—obesity	2.88e-06	6.31e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GOT1—obesity	2.87e-06	6.3e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GGT1—obesity	2.87e-06	6.3e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALB—obesity	2.85e-06	6.25e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NCOA1—obesity	2.83e-06	6.21e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—STK11—obesity	2.79e-06	6.12e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP19A1—obesity	2.79e-06	6.12e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NOS3—obesity	2.72e-06	5.98e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3R1—obesity	2.72e-06	5.98e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—STAT3—obesity	2.66e-06	5.84e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—COMT—obesity	2.59e-06	5.69e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GNB3—obesity	2.56e-06	5.61e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARGC1A—obesity	2.56e-06	5.61e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMOX1—obesity	2.55e-06	5.58e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3CB—obesity	2.51e-06	5.52e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—obesity	2.49e-06	5.47e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GNAS—obesity	2.49e-06	5.46e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—MYC—obesity	2.48e-06	5.43e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—obesity	2.47e-06	5.42e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIK3CA—obesity	2.45e-06	5.37e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOB—obesity	2.44e-06	5.35e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPL—obesity	2.33e-06	5.11e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GPX1—obesity	2.27e-06	4.98e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CD36—obesity	2.21e-06	4.85e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIK3CA—obesity	2.1e-06	4.61e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MTHFR—obesity	2.1e-06	4.6e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARA—obesity	2.06e-06	4.51e-05	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—AKT1—obesity	2e-06	4.39e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AGT—obesity	1.99e-06	4.37e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOE—obesity	1.95e-06	4.28e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CAV1—obesity	1.93e-06	4.24e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—APOA1—obesity	1.93e-06	4.23e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—obesity	1.86e-06	4.08e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIK3CA—obesity	1.77e-06	3.88e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3CG—obesity	1.76e-06	3.86e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AKT1—obesity	1.72e-06	3.77e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARG—obesity	1.7e-06	3.73e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—obesity	1.68e-06	3.68e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—INS—obesity	1.67e-06	3.66e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3CD—obesity	1.55e-06	3.4e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIK3CA—obesity	1.53e-06	3.36e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALB—obesity	1.53e-06	3.35e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NOS3—obesity	1.46e-06	3.21e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3R1—obesity	1.46e-06	3.21e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AKT1—obesity	1.45e-06	3.17e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3CB—obesity	1.35e-06	2.96e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—obesity	1.34e-06	2.93e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AKT1—obesity	1.25e-06	2.75e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIK3CA—obesity	8.23e-07	1.8e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AKT1—obesity	6.72e-07	1.47e-05	CbGpPWpGaD
